Yayın:
Targeted and epigenetic therapies for acute myeloid leukemia treatment

dc.contributor.authorArian, Homaira
dc.contributor.authorMobin Ghaderi
dc.contributor.authorMilad Mokarami
dc.contributor.authorHomaira Arian
dc.contributor.authorSara Mohammadnabi
dc.contributor.authorAfsaneh Farokhi
dc.date.accessioned2025-11-13T12:10:41Z
dc.date.issued2025-09-26
dc.identifier.doihttps://doi.org/10.1007/s12672-025-03534-8
dc.identifier.endpage1711
dc.identifier.issn2730-6011
dc.identifier.issue1
dc.identifier.openalexW4414554860
dc.identifier.startpage1711
dc.identifier.urihttps://hdl.handle.net/11421/9204
dc.identifier.urihttps://doi.org/10.1007/s12672-025-03534-8
dc.identifier.volume16
dc.language.isoen
dc.relation.ispartofDiscover Oncology
dc.rightsopenAccess
dc.titleTargeted and epigenetic therapies for acute myeloid leukemia treatment
dc.typeArticle
dspace.entity.typePublication
local.authorid.openalexA5116183426

Dosyalar

Koleksiyonlar